Mengping Liu

发表

HCV NS5A replication complex inhibitors. Part 5: discovery of potent and pan-genotypic glycinamide cap derivatives.

A. Good, N. Meanwell, J. Lemm, 2013, Bioorganic & medicinal chemistry letters.

Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus.

Carl T. Bergstrom, Chong-Hwan Chang, M. Witmer, 2011, Bioorganic & medicinal chemistry letters.

Discovery of BMS-961955, an allosteric inhibitor of the hepatitis C virus NS5B polymerase.

A. Mathur, J. Cutrone, N. Meanwell, 2017, Bioorganic & medicinal chemistry letters.

β-Alanine and α-fluoro-β-alanine concentrative transport in rat hepatocytes is mediated by GABA transporter GAT-2.

R. Handschumacher, L. Beigelman, Mengping Liu, 1999, American journal of physiology. Gastrointestinal and liver physiology.

Lead competition alters the zinc adsorption mechanism on animal-derived biochar.

Ling-hong Zhu, Y. Qiu, Junliang Wang, 2020, The Science of the total environment.

Replication-Competent Chimeric Hepatitis C Virus Subgenomic Replicons

J. Lemm, R. Colonno, M. Gao, 2005, Intervirology.

Improving Metabolic Stability with Deuterium: The Discovery of BMT-052, a Pan-genotypic HCV NS5B Polymerase Inhibitor.

N. Meanwell, J. Lemm, K. Yeung, 2017, ACS medicinal chemistry letters.

Insight into the role of ion-pairing in the adsorption of imidazolium derivative-based ionic liquids by activated carbon.

Ling-hong Zhu, Y. Qiu, Mengping Liu, 2020, The Science of the total environment.

Phosphorolytic Activity in Selected Human Tumors Phosphorylase and Identification of Variant Uridine Expression , Characterization , and Detection of Human Uridine Updated

D. Cao, R. Handschumacher, Mengping Liu, 2006 .

The lifestyle factors of physical activity and diet balance associated with HPV infection in China: The cross-sectional study

A. Wang, Mengping Liu, Yuxin Jiang, 2022, Frontiers in Oncology.

HCV NS5A replication complex inhibitors. Part 4. Optimization for genotype 1a replicon inhibitory activity.

N. Meanwell, J. Lemm, B. Pearce, 2014, Journal of medicinal chemistry.

Structural effect of imidazolium-type ionic liquid adsorption to montmorillonite.

Y. Qiu, Junliang Wang, Mengping Liu, 2019, Science of the Total Environment.

Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymerase.

Chong-Hwan Chang, M. Witmer, B. Beno, 2014, Journal of medicinal chemistry.

Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: potent allosteric inhibitors of the hepatitis C virus NS5B polymerase.

B. Beno, M. Poss, J. Lemm, 2012, Bioorganic & medicinal chemistry letters.

HCV NS5A replication complex inhibitors. Part 3: discovery of potent analogs with distinct core topologies.

A. Good, N. Meanwell, J. Lemm, 2013, Bioorganic & medicinal chemistry letters.

Preclinical Characterization of BMS-791325, an Allosteric Inhibitor of Hepatitis C Virus NS5B Polymerase

N. Meanwell, J. Lemm, R. Colonno, 2014, Antimicrobial Agents and Chemotherapy.

Effect on Hepatitis C Virus Replication of Combinations of Direct-Acting Antivirals, Including NS5A Inhibitor Daclatasvir

J. Lemm, M. Gao, Mengping Liu, 2012, Antimicrobial Agents and Chemotherapy.

Effect on HCV Replication by Combinations of Direct Acting Antivirals 5 Including NS 5 A Inhibitor Daclatasvir 6 7 8

J. Lemm, M. Gao, Mengping Liu, 2012 .

Protein corona-mediated transport of nanoplastics in seawater-saturated porous media.

Y. Qiu, Junliang Wang, Mengping Liu, 2020, Water research.

Structure-Property Basis for Solving Transporter-Mediated Efflux and Pan-Genotypic Inhibition in HCV NS5B Inhibitors.

M. Witmer, B. Beno, K. Kish, 2018, ACS medicinal chemistry letters.

Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.

Qi Gao, Min Gao, Steven Sheriff, 2017, Journal of medicinal chemistry.

Potency and Resistance Analysis of Hepatitis C Virus NS5B Polymerase Inhibitor BMS-791325 on All Major Genotypes

J. Lemm, M. Gao, Mengping Liu, 2014, Antimicrobial Agents and Chemotherapy.

Identification of Hepatitis C Virus NS5A Inhibitors

N. Meanwell, M. Deshpande, Scott W. Martin, 2009, Journal of Virology.

SAR studies on a series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides: potent inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus.

B. Beno, M. Poss, J. Lemm, 2011, Bioorganic & medicinal chemistry letters.

Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymerase.

M. Witmer, B. Beno, K. Kish, 2011, Bioorganic & medicinal chemistry letters.

Conserved Fungal Genes as Potential Targets for Broad-Spectrum Antifungal Drug Discovery

B. Dougherty, D. Davison, R. Bruccoleri, 2006, Eukaryotic Cell.

Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5A

Min Gao, Nicholas A. Meanwell, Yong Tu, 2015, Nature.

Structure-Dependent Fenton Reactivity and Degradation Pathway of Methylimidazolium Ionic Liquids

Ling-hong Zhu, Y. Qiu, Mengping Liu, 2020, ACS ES&T Water.

HCV NS5A replication complex inhibitors. Part 2: investigation of stilbene prolinamides.

N. Meanwell, J. Lemm, M. Gao, 2012, Bioorganic & medicinal chemistry letters.

Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5A

N. Meanwell, D. Langley, J. Lemm, 2015, Nature.